Fraunhofer ITMPThe Fraunhofer Institute for Translational Medicine and Pharmacology ITMP investigates and develops innovative ways of early detection, diagnosis and treatment of diseases resulting from impaired function of the immune system.
The Fraunhofer Institute for Translational Medicine and Pharmacology ITMP investigates three research areas “Drug Discovery”, “Preclinical Research” and “Clinical Research”. Fraunhofer ITMP is a competent partner for universities, for translating medical research findings into valuable assets, as well as for the pharmaceutical and biotechnological industry.
The institute currently employs about 237 people at its locations Frankfurt am Main, Hamburg, Göttingen, Berlin and Penzberg/Munich. It is scientifically closely linked to a large number of institutes and clinics of the University Hospital of the Goethe University Frankfurt am Main, the University Hospital Hamburg-Eppendorf, the University Medical Center Göttingen, the Charité, the Ludwig-Maximilians-University and the LMU Medical Center.
The Hamburg site is one of the world's leading institutions for identifying pharmacologically active substances using screening methodologies.
- High throughput drug discovery (in silico, in vitro "screening" and drug repurposing) as well as a broad range of services in the field of "Medical Data Science".
- Comprehensive portfolio of phenotypic and biochemical assays
- in vitro models based on induced pluripotent stem cells
- "Medical Data Science" (development of workflows, algorithms and dashboards, cohort analysis, FAIR data management, Fraunhofer Edge Cloud Health)